BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 33294269)

  • 21. A candidate precursor to serous carcinoma that originates in the distal fallopian tube.
    Lee Y; Miron A; Drapkin R; Nucci MR; Medeiros F; Saleemuddin A; Garber J; Birch C; Mou H; Gordon RW; Cramer DW; McKeon FD; Crum CP
    J Pathol; 2007 Jan; 211(1):26-35. PubMed ID: 17117391
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Significance and expression of PAX8, PAX2, p53 and RAS in ovary and fallopian tubes to origin of ovarian high grade serous carcinoma].
    Mao YN; Zeng LX; Li YH; Liu YZ; Wu JY; Li L; Wang Q
    Zhonghua Fu Chan Ke Za Zhi; 2017 Oct; 52(10):687-696. PubMed ID: 29060967
    [No Abstract]   [Full Text] [Related]  

  • 23. Serous carcinogenesis in the fallopian tube: a descriptive classification.
    Jarboe E; Folkins A; Nucci MR; Kindelberger D; Drapkin R; Miron A; Lee Y; Crum CP
    Int J Gynecol Pathol; 2008 Jan; 27(1):1-9. PubMed ID: 18156967
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: Evidence for a causal relationship.
    Kindelberger DW; Lee Y; Miron A; Hirsch MS; Feltmate C; Medeiros F; Callahan MJ; Garner EO; Gordon RW; Birch C; Berkowitz RS; Muto MG; Crum CP
    Am J Surg Pathol; 2007 Feb; 31(2):161-9. PubMed ID: 17255760
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Incidental nonuterine high-grade serous carcinomas arise in the fallopian tube in most cases: further evidence for the tubal origin of high-grade serous carcinomas.
    Gilks CB; Irving J; Köbel M; Lee C; Singh N; Wilkinson N; McCluggage WG
    Am J Surg Pathol; 2015 Mar; 39(3):357-64. PubMed ID: 25517954
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nongynecologic metastases to fallopian tube mucosa: a potential mimic of tubal high-grade serous carcinoma and benign tubal mucinous metaplasia or nonmucinous hyperplasia.
    Rabban JT; Vohra P; Zaloudek CJ
    Am J Surg Pathol; 2015 Jan; 39(1):35-51. PubMed ID: 25025442
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serous tubal intraepithelial carcinoma localizes to the tubal-peritoneal junction: a pivotal clue to the site of origin of extrauterine high-grade serous carcinoma (ovarian cancer).
    Seidman JD
    Int J Gynecol Pathol; 2015 Mar; 34(2):112-20. PubMed ID: 25675178
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The association of serous tubal intraepithelial carcinoma with gynecologic pathologies and its role in pelvic serous cancer.
    Koç N; Ayas S; Uygur L
    Gynecol Oncol; 2014 Sep; 134(3):486-91. PubMed ID: 25038287
    [TBL] [Abstract][Full Text] [Related]  

  • 29. p53 signature and serous tubal in-situ carcinoma in cases of primary tubal and peritoneal carcinomas and serous borderline tumors of the ovary.
    Leonhardt K; Einenkel J; Sohr S; Engeland K; Horn LC
    Int J Gynecol Pathol; 2011 Sep; 30(5):417-24. PubMed ID: 21804388
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High-grade serous ovarian and fallopian tube carcinomas with similar clinicopathological characteristics might originate from serous tubal intraepithelial carcinoma in Chinese women.
    Wang J; Wu H; Zhang Y; Zhang Y; Li X; Zhao Q; Meng F; Huang Q; Wang Y
    Int J Clin Exp Pathol; 2017; 10(8):8222-8232. PubMed ID: 31966673
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinically occult tubal and ovarian high-grade serous carcinomas presenting in uterine samples: diagnostic pitfalls and clues to improve recognition of tumor origin.
    Bagby C; Ronnett BM; Yemelyanova A; Maleki Z; Kuhn E; Vang R
    Int J Gynecol Pathol; 2013 Sep; 32(5):433-43. PubMed ID: 23896706
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Two types of ovarian cortical inclusion cysts: proposed origin and possible role in ovarian serous carcinogenesis.
    Banet N; Kurman RJ
    Int J Gynecol Pathol; 2015 Jan; 34(1):3-8. PubMed ID: 25473746
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Extrauterine Pelvic Serous Carcinomas: Current Update on Pathology and Cross-sectional Imaging Findings.
    Katabathina VS; Amanullah FS; Menias CO; Chen MM; Valente PT; Chintapalli KN; Prasad SR
    Radiographics; 2016; 36(3):918-32. PubMed ID: 27163599
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Should All Cases of High-Grade Serous Ovarian, Tubal, and Primary Peritoneal Carcinomas Be Reclassified as Tubo-Ovarian Serous Carcinoma?
    Moss EL; Evans T; Pearmain P; Askew S; Singh K; Chan KK; Ganesan R; Hirschowitz L
    Int J Gynecol Cancer; 2015 Sep; 25(7):1201-7. PubMed ID: 26035124
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PAX2-null secretory cell outgrowths in the oviduct and their relationship to pelvic serous cancer.
    Quick CM; Ning G; Bijron J; Laury A; Wei TS; Chen EY; Vargas SO; Betensky RA; McKeon FD; Xian W; Crum CP
    Mod Pathol; 2012 Mar; 25(3):449-55. PubMed ID: 22080059
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The fallopian tube: primary site of most pelvic high-grade serous carcinomas.
    Salvador S; Gilks B; Köbel M; Huntsman D; Rosen B; Miller D
    Int J Gynecol Cancer; 2009 Jan; 19(1):58-64. PubMed ID: 19258943
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Current FIGO staging classification for cancer of ovary, fallopian tube and peritoneum].
    Šišovská I; Minář L; Felsinger M; Anton M; Bednaříková M; Hausnerová J; Jandáková E; Weinberger V
    Ceska Gynekol; 2017; 82(3):230-236. PubMed ID: 28593778
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The conceptual advances of carcinogenic sequence model in high-grade serous ovarian cancer.
    Kobayashi H; Iwai K; Niiro E; Morioka S; Yamada Y; Ogawa K; Kawahara N
    Biomed Rep; 2017 Sep; 7(3):209-213. PubMed ID: 28811894
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Morphological features of the fimbria of the fallopian tube in pelvic serous adenocarcinoma].
    Guo DH; Pang SJ; Shen Y; Li Y
    Zhonghua Zhong Liu Za Zhi; 2011 Apr; 33(4):287-90. PubMed ID: 21575501
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    Laban M; Ibrahim EA; Hassanin AS; Nasreldin MA; Mansour A; Khalaf WM; Bahaa Eldin AM; Hussain SH; Elsafty MS; Hasanien AS
    Int J Womens Health; 2019; 11():199-205. PubMed ID: 30962726
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.